Abiopharma

🔍 Thota Chandrasekhar (Director)

Company: Dynatrace, Inc. (DT)

Report Date: 2026-07-27

Detailed Transactions and Holdings:

• Acquired 10,522 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,522.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1

Footnotes:

• F1: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date.
• F2: Represents the grant of RSUs under the Issuer's 2019 Equity Incentive Plan, as amended, and the Amended and Restated Non-Employee Director Compensation Policy. 25% of these RSUs will vest on July 27, 2027, and the balance of the RSUs will vest in equal quarterly installments thereafter until fully vested on July 27, 2030, subject to the Reporting Person's continued service as a director on the applicable vesting dates.